Skip to main content
. 2023 Jul 24;9(3):20552173231187810. doi: 10.1177/20552173231187810

Figure 2.

Figure 2.

Study population demographics and MS disease characteristics. DMT, disease-modifying therapy; EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; NTD, NeuroTransData; RRMS, relapsing-remitting multiple sclerosis; SD, standard deviation.